Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.7B |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$593M |
| 3 |
Meta Platforms (Facebook)
META
|
+$508M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$460M |
| 5 |
Netflix
NFLX
|
+$323M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$478M |
| 2 |
RTN
Raytheon Company
RTN
|
+$318M |
| 3 |
Merck
MRK
|
+$257M |
| 4 |
Johnson & Johnson
JNJ
|
+$251M |
| 5 |
Qualcomm
QCOM
|
+$240M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.89% |
| 2 | Healthcare | 14.18% |
| 3 | Financials | 11.46% |
| 4 | Consumer Discretionary | 10.84% |
| 5 | Industrials | 8.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2001
iShares 0-5 Year TIPS Bond ETF
STIP
$15.9B
| $7.38M | ﹤0.01% |
72,109
+294
| +0.4% | +$29.8K |
|
|
FSP
2002
Franklin Street Properties
FSP
$50.8M
| $7.38M | ﹤0.01% |
1,449,272
-31,202
| -2% | -$165K |
|
|
AUY
2003
DELISTED
Yamana Gold, Inc.
AUY
| $7.37M | ﹤0.01% |
1,350,050
+1,085,576
| +410% | +$5.19M |
|
|
DRNA
2004
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $7.35M | ﹤0.01% |
289,279
+38,893
| +16% | +$838K |
|
2005
Bilibili
BILI
$7.3B
| $7.33M | ﹤0.01% |
158,189
+119,216
| +306% | +$3.87M |
|
2006
Opko Health
OPK
$1.03B
| $7.32M | ﹤0.01% |
2,146,416
+292,591
| +16% | +$655K |
|
|
EBIX
2007
DELISTED
Ebix Inc
EBIX
| $7.32M | ﹤0.01% |
327,308
+2,959
| +0.9% | +$61K |
|
2008
iShares MSCI Japan ETF
EWJ
$23.2B
| $7.32M | ﹤0.01% |
133,190
-11,177
| -8% | -$593K |
|
2009
HealthStream
HSTM
$846M
| $7.28M | ﹤0.01% |
328,732
+11,213
| +4% | +$260K |
|
2010
Middlesex Water
MSEX
$1.11B
| $7.27M | ﹤0.01% |
108,240
-2,321
| -2% | -$147K |
|
|
SAVE
2011
DELISTED
Spirit Airlines, Inc.
SAVE
| $7.27M | ﹤0.01% |
408,302
+90,217
| +28% | +$1.29M |
|
2012
Howard Hughes
HHH
$3.98B
| $7.26M | ﹤0.01% |
146,680
-2,531
| -2% | -$127K |
|
2013
Inogen
INGN
$153M
| $7.26M | ﹤0.01% |
204,281
+1,287
| +0.6% | +$54.2K |
|
|
GES
2014
DELISTED
Guess Inc
GES
| $7.25M | ﹤0.01% |
749,937
-30,182
| -4% | -$266K |
|
2015
Orthofix Medical
OFIX
$421M
| $7.25M | ﹤0.01% |
226,434
+15,122
| +7% | +$502K |
|
2016
ICF International
ICFI
$1.59B
| $7.23M | ﹤0.01% |
111,496
-3,457
| -3% | -$227K |
|
|
OSG
2017
Octave Specialty Group
OSG
$221M
| $7.22M | ﹤0.01% |
504,241
-8,290
| -2% | -$121K |
|
2018
Scansource
SCSC
$1.08B
| $7.22M | ﹤0.01% |
299,531
-6,027
| -2% | -$143K |
|
2019
First Busey Corp
BUSE
$2.58B
| $7.21M | ﹤0.01% |
386,559
-1,820
| -0.5% | -$31.5K |
|
|
ALLK
2020
DELISTED
Allakos
ALLK
| $7.21M | ﹤0.01% |
100,284
+14,273
| +17% | +$956K |
|
2021
Simply Good Foods
SMPL
$1B
| $7.18M | ﹤0.01% |
386,522
-20,152
| -5% | -$357K |
|
|
CYBR
2022
DELISTED
CyberArk
CYBR
| $7.18M | ﹤0.01% |
72,295
+5,379
| +8% | +$523K |
|
2023
Select Water Solutions
WTTR
$2.69B
| $7.17M | ﹤0.01% |
1,462,184
-10,433
| -0.7% | -$47.8K |
|
|
BBT
2024
Beacon Financial Corp
BBT
$2.69B
| $7.14M | ﹤0.01% |
647,827
+2,991
| +0.5% | +$38.4K |
|
2025
Vanda Pharmaceuticals
VNDA
$316M
| $7.13M | ﹤0.01% |
623,590
+23,031
| +4% | +$261K |
|
Similar funds
Bank of New York Mellon's Q2 2020 Portfolio in Review
As of Q2 2020, Bank of New York Mellon held 4,266 positions worth $375B, up 24% from $302B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Bank of New York Mellon's Q2 2020 filing shows 170 new, 1,923 increased, 1,788 reduced and 190 closed positions. Its largest new stake was Otis Worldwide: 5,903,383 shares worth $336M. The largest sale was Allergan plc, an estimated $478M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
- Bank of New York Mellon's largest Q2 2020 buy was Otis Worldwide: 5,903,383 shares worth $336M.
- Bank of New York Mellon added most to Amazon in Q2 2020, an estimated $1.7B increase.
- Bank of New York Mellon's biggest Q2 2020 reduction was Merck, cutting an estimated $257M.
- Bank of New York Mellon fully exited Allergan plc in Q2 2020, selling an estimated $478M.
- Bank of New York Mellon's ten largest holdings make up 21% of its $375B portfolio in Q2 2020.
- Bank of New York Mellon opened 170 new positions and closed 190 in Q2 2020.
- Bank of New York Mellon's portfolio value rose 24% quarter-over-quarter to $375B.
Based on Bank of New York Mellon's 13F filing for Q2 2020, filed 12 Aug 2020.